Sign up


Match Document Document Title
8460686 Bioactive bone graft substitute  
The invention relates to biocompatible bone graft materials for repairing bone defects and the application of such bone grafts. The devices of the invention comprise resorbable calcium phosphate,...
8460684 Nuclease inhibitors and methods for their use  
A class of anionic oligomers and polymers that function for inhibition of nucleases, particularly RNase. Specific inhibitors include mixtures of oligomers of vinyl sulfate. Methods for inhibition...
8460741 Process for the preparation of a canola protein isolate  
A novel canola protein isolate with predominantly of 2S canola protein and having equal to better solubility properties and improved clarity properties, has an increased proportion of 2S canola...
8460714 Purified amniotic membrane compositions and methods of use  
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and ...
8461091 Personal care composition in the form of an article having a porous, dissolvable solid structure  
The present invention relates to a dissolvable article in the form of a porous dissolvable solid structure, comprising from about 10% to about 50% water soluble polymer; from about 1% to about 25%...
8460685 Method of improving the osteoinductivity of calcium phosphate  
The invention relates to methods of improving the osteoinductivity of calcium phosphate materials, to calcium phosphate materials having improved osteoinductivity as well as bone (re)generation...
8460641 Microemulsion process and composition  
An oil-in-water microemulsion or sub-micron emulsion composition for dermal delivery of at least one pharmaceutically active ingredient, comprising: a first part including at least one occlusive...
8461090 Personal care composition in the form of an article having a porous, dissolvable solid structure  
The present invention relates to a dissolvable article in the form of a porous dissolvable solid structure, comprising from about 23% to about 75% surfactant; wherein the surfactant has an average...
8461224 Single monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery  
A method of synthesizing a random copolymer of polyethyleneimine and polyethylene glycol, comprising exposing ethanolamine in a solution to electromagnetic radiation for a sufficient time to...
8454994 Stable pharmaceutical composition and methods of using same  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
8455005 Method and compositions for improving animal health  
Products as well as methods for reducing plaque in a domestic animal are provided. The product comprises retorted milk.
8455459 Method of applying an injectable filler  
Methods for applying injectable fillers are provided. In some embodiments, the methods can extend effectiveness of the injectable filler. In some embodiments, the methods can provide for an...
8455004 Primary composition comprising a lipophilic bioactive compound  
The invention relates to a primary composition in which at least one lipophilic bioactive compound is mixed with a whey protein, present in an amount effective to increase the bioavailability of...
8454980 Hydrogel bioscaffold and coating for bone and tooth repair  
Hydrogel compositions that include an albumin/N-acetyl cysteine solution and an aqueous suspension of calcium salts or mixture of calcium and magnesium salts are described. Also described are...
8455009 Amniotic membrane preparations and purified compositions and anti-inflammation methods  
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and ...
8455524 Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions  
Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular...
8449878 Prebiotic formulations for use with probiotics to increase probiotic growth rate and activity  
Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate...
8449867 Microemulsion and sub-micron emulsion process and compositions  
An oil in water microemulsion or sub-micron emulsion composition for dermal delivery of at least one pharmaceutically active ingredient, is provided. The composition includes an oil phase dispersed...
8449895 Conditioning cleansing cream  
A conditioning cleansing cream for removing oil and debris from the hair while leaving it soft, detangled, and conditioned is provided. The conditioning cleansing cream comprises an amount of...
8450375 Stabilized compositions of volatile alkylating agents and methods of using thereof  
A composition and method for treatment of cancer. The composition for treating a skin disorder, comprising: a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, wherein the Nitrogen Mustard or...
8449896 Pharmaceutical composition having improved solubility  
It is desired to provide a pharmaceutical composition containing a compound represented by formula (I) or a pharmacologically acceptable salt thereof, or a solvate thereof, which exhibits an...
8444967 Treatment including prebiotic composition for use with probiotics  
A method is described to treat diarrhea, vaginal yeast infections, constipation, heartburn, bloating, indigestion, flatulence or poor nutrient absorption, by administering a formulation of...
8445013 Stable pharmaceutical composition and methods of using same  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
8445015 Extended-release formulation for reducing the frequency of urination and method of use thereof  
Methods and compositions for reducing the frequency of urination are disclosed. One method comprises administering to a subject in need thereof an effective amount of a pharmaceutical composition...
8445002 Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same  
Dermal delivery compositions are provided. Aspects of the dermal delivery compositions include the presence of active agent-calcium phosphate particle complexes, where these complexes include...
8445528 Dendrimer conjugates  
The present invention relates to novel therapeutic and diagnostic dendrimers. In particular, the present invention is directed to dendrimer-linker conjugates, methods of synthesizing the same,...
8445003 Stable pharmaceutical composition and methods of using same  
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular related diseases.
8445020 High-loading, controlled-release magnesium oral dosage forms and methods of making and using same  
Disclosed are high-loading, controlled-release dosage forms for oral administration of magnesium salts. For example, an oral dosage form can comprise from about 80% to about 95% magnesium lactate...
8440210 Stabilized pharmaceutical product  
Use of an adsorbent and a sealed package (e.g. an overwrap) to protect a pharmaceutical product in a solid state in the presence of a reducing sugar.
8440232 Methods of treatment using a gastric retained gabapentin dosage  
A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.
8440235 Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition  
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and ...
8440217 Method and system with contact lens product for treating and preventing adverse eye conditions  
A contact lens product, a method and system for forming the contact lens product, and a method of using the contact lens product. The contact lens product includes a soft disposable contact lens...
8440209 Adhesive for medical applications and means for haemostasis  
The invention relates to adhesives for medical applications and methods of their preparation and use.
8435551 Cancellous construct with support ring for repair of osteochondral defects  
The invention is directed toward an osteochondral repair assembly comprising a shaped allograft construct comprising an unbalanced barbell-shaped cylindrical cancellous bone primary member formed...
8435502 Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers  
Cosmetic/dermatological compositions for topical application and useful for the treatment, e.g., of acne, contain, formulated into a physiologically acceptable medium, at least one naphthoic acid...
8435544 Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors  
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or...
8435545 Capsule having broad color spectrum  
The present invention is directed to a capsule comprising a water-soluble compound suitable for the capsule, and a mixture of colorant agents, wherein the color of the capsule may be in the range...
8435500 Nail whitening composition  
A cosmetic composition for bleaching discolored nails containing at least one hydrogen peroxide generator in an amount sufficient to perform bleaching of discolored nails, at least one film forming...
8435553 Elastin stabilization of connective tissue  
A method and product are provided for the treatment of connective tissue weakened due to destruction of tissue architecture, and in particular due to elastin degradation. The treatment agents...
8431143 Therapeutic method of administering pharmaceutical titanium dioxide composite and light irradiation  
A titanium dioxide composite is provided that can be stably dispersed in an aqueous solvent and easily administered into a living body, such as human, and allows elimination of the drug efficacy of...
8431221 Therapeutic calcium phosphate particles and methods of manufacture and use  
Novel calcium phosphate core particles, methods of making them, and methods of using them as vaccine adjuvants, as cores, as carriers of biologically active material, and as controlled release...
8426466 Compositions and methods for enhancing active agent absorption  
Compositions and methods for enhancing the absorption of active agents across the mucosa of animal subjects are provided. Methods of administration and appropriate dosage forms are also provided.
8425923 Lotion composition for personal use  
This invention relates to emulsion compositions that can warm on contact with ambient moisture and can be used as lubricants on the skin of a person. They may be formulated in the form of a lotion...
8425879 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy  
Nanovectors are disclosed that make it possible to simultaneously target, image, and treat cancerous cells using photodynamic therapy. Also disclosed are novel molecules (I) derived from...
8420108 Flexible bone composite  
The present invention relates in general to implantable flexible bone composites, and method for preparing the same. The flexible bone composite includes at least one polymeric layer and at least...
8420057 Capsule having broad color spectrum  
The present invention is directed to a capsule comprising a water-soluble compound suitable for the capsule, a non-water soluble excipient suitable for the capsule; and suitable for the capsule,...
8420851 Selective TR-β 1 agonist  
The present invention relates to novel compounds of general formula (I) which are thyroid receptor ligands and are preferably selective for the thyroid hormone receptor beta (TR-Beta). Further, the...
8420662 Stable solid preparation containing 4,5-epoxymorphinan derivative  
It is an object of the present invention to provide a stable solid preparation comprising a 4,5-epoxymorphinan derivative or a pharmacologically acceptable acid addition salt thereof as an...
8420105 Botulinum toxin administration to treat various conditions  
Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The...
8420126 Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment  
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and ...